Advertisement
Advertisement

AGIO

AGIO logo

Agios Pharmaceuticals, Inc.

32.38
USD
-1.66
-4.89%
Mar 07, 15:59 UTC -5
Closed
exchange

After-Market

32.38

0
0.00%

Agios Pharmaceuticals, Inc. Profile

About

Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases.

Info & Links

CEO

Brian Goff

Headquarters

88 SIDNEY STREET
CAMBRIDGE, MA 02139, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.agios.com

Auditor

PricewaterhouseCoopers LLP

Share holders

9

Employees

488

Agios Pharmaceuticals, Inc. Statistics

Valuation Measures

Market Capitalization2

1.86B

Enterprise Value

1.78B

Enterprise Value/EBITDA(ttm)

-4.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

52.98

Price to Book(mrq)

1.25

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

88.63%

Operating Margin(ttm)

-78.61%

Profit Margin(ttm)

1890.90%

Return on Equity(ttm)

-2.51%

Return on Invested Capital(ttm)

26.50%

Return on Assets(ttm)

-2.26%

Income Statement

Revenue(ttm)

36.50M

Revenue Per Share(ttm)

0.64

Gross Profit(ttm)

32.33M

EBITDA(ttm)3

-434.57M

Net Income Available to Common(ttm)

673.72M

Diluted EPS(ttm)

11.34

Share Statistics

Beta (5Y Monthly)

0.88

52-Week Change

3.22%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.30M

Dividend Yield

0.00%

Float4

54.47M

% Held by Insiders

4.93%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

893.71M

Total Cash Per Share(mrq)

15.60

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.90%

Quick Ratio(mrq)

11.56%

Book Value Per Share(mrq)

26.96

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.73

Free Cash Flow(ytd)

-391.49M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement